Abstract | PURPOSE: The aim of this study was to compare the serum levels of one- carbon metabolism (OCM) nutrients (e.g., folate, homocysteine and vitamin B12) and peripheral blood DNA methylation in epileptic patients under treatment with antiepileptic drugs (AEDs) and in healthy controls. METHODS: In this cross-sectional study, 60 patients with epilepsy who were receiving valproate (VPA) ( n = 30) or lamotrigine (LTG) ( n = 30) monotherapy were enrolled. Thirty age and sex matched healthy subjects served as the controls. Serum concentrations of OCM nutrients and peripheral blood DNA methylation status were measured. RESULTS: Compared to the control group, the VPA group had higher serum levels of homocysteine (p<0.05). No difference in homocysteine concentration was observed in the LTG group. Patients receiving VPA or LTG had significantly lower serum folate levels in comparison with controls (p<0.001). The level of methylation of long interspersed nucleotide element-1 (LINE-1) in peripheral blood was not significantly different between the AED monotherapy group and healthy controls. A difference in the methylation levels of methylenetetrahydrofolate reductase (MTHFR) amplicon was observed between AED-treated patients with epilepsy and controls (p<0.01). A positive correlation between serum folate levels and peripheral blood MTHFR amplicon methylation status was also observed (r = 0.25, p = 0.023). CONCLUSION: Our findings suggest that the effects of AED monotherapy on OCM may induce specific regions of DNA hypomethylation.
|
Authors | Guanzhong Ni, Jiaming Qin, Hongliang Li, Ziyi Chen, Yafang Zhou, Ziyan Fang, Yishu Chen, Jueqian Zhou, Min Huang, Liemin Zhou |
Journal | PloS one
(PLoS One)
Vol. 10
Issue 4
Pg. e0125656
( 2015)
ISSN: 1932-6203 [Electronic] United States |
PMID | 25915064
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticonvulsants
- Heterocyclic Compounds
- Triazines
- Homocysteine
- Valproic Acid
- Folic Acid
- MTHFR protein, human
- Methylenetetrahydrofolate Reductase (NADPH2)
- Vitamin B 12
- Lamotrigine
|
Topics |
- Adolescent
- Adult
- Anticonvulsants
(pharmacology, therapeutic use)
- Case-Control Studies
- Cross-Sectional Studies
- DNA Methylation
(drug effects)
- Epilepsy
(blood, drug therapy, genetics)
- Female
- Folic Acid
(blood)
- Heterocyclic Compounds
(blood)
- Homocysteine
(blood)
- Humans
- Lamotrigine
- Long Interspersed Nucleotide Elements
- Male
- Methylenetetrahydrofolate Reductase (NADPH2)
(genetics)
- Middle Aged
- Triazines
(pharmacology, therapeutic use)
- Valproic Acid
(pharmacology, therapeutic use)
- Vitamin B 12
(blood)
- Young Adult
|